Comorbidities can complicate cancer treatment by limiting the options available or affecting how the patient tolerates treatments. For instance, a patient with chronic kidney disease may not be able to undergo certain chemotherapy regimens due to the risk of nephrotoxicity. In such cases, the treatment plan must be tailored to minimize risks while effectively targeting the cancer.
